The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1059
August 13, 1999
View Complete Issue         Table of Contents 2019 
Malathion for the Treatment of Head Lice
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Malathion for the Treatment of Head Lice
August 13, 1999 (Issue: 1059)
0.5% malathion in 78% isopropanol was recently approved by the FDA for treatment of head lice.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Malathion for the Treatment of Head Lice
Article code: 1059b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.